Liposomal supplements market seen reaching $1.61 billion by 2030

The liposomal supplements market is projected to grow from $1.07 billion in 2025 to $1.61 billion by 2030, fueled by demand for better nutrient absorption, preventive health products and personalized nutrition. North America led in 2025, while Asia-Pacific is expected to grow the fastest through the forecast period.

Why it matters: - Liposomal supplements are gaining share in the broader nutraceutical and preventive healthcare markets as consumers look for products designed to improve nutrient absorption and bioavailability. - The market’s projected rise to $1.61 billion by 2030 signals continued demand for advanced supplement formats across beauty, wellness and clinical nutrition.

What happened: - The Business Research Company’s Liposomal Supplements Global Market Report 2026 forecasts the market at $1.07 billion in 2025 and $1.16 billion in 2026. - The report projects the market will reach $1.61 billion by 2030, implying an 8.6% CAGR from 2026 to 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - A free sample of the report is available here. - The full report is available here.

The details: - Liposomal supplements use microscopic lipid-based vesicles called liposomes to protect active ingredients during digestion. - The encapsulation helps move ingredients into the bloodstream and improve bioavailability. - Growth is being driven by rising interest in preventive health supplements, more nutrient deficiencies and lifestyle-related illnesses, and a larger nutraceutical industry. - Better retail availability and advances in pharmaceutical drug delivery technologies are also supporting expansion. - The report points to growing demand for personalized nutrition and precision wellness. - AI-powered formulation and product design are emerging as part of the market’s next phase. - The report also flags aging populations, stronger clinical evidence for liposomal delivery, cleaner-label products and plant-based formulations as important trends. - Use in sports nutrition and clinical wellness is expanding.

Between the lines: - Anti-aging and skin health products are a major demand driver because consumers are prioritizing hydration, protection and repair in daily skincare routines. - Liposomal supplements fit that trend by delivering collagen, antioxidants and vitamins in forms designed for better absorption. - Australian Bureau of Statistics data from September 2024 showed 38.1% of people aged 15 and older used SPF30 or higher sunscreen regularly during late spring and summer of 2023-24, underscoring a broader preventive skincare mindset. - The market’s growth reflects a shift from basic supplementation toward products positioned around measurable delivery and targeted wellness outcomes.

What's next: - The market is expected to keep growing as personalized nutrition, genetic-profile-based supplements and AI-assisted product development move further into mainstream formulation. - Asia-Pacific’s growth trajectory suggests more competition and distribution focus in the region over the next several years. - Further clinical validation of liposomal delivery systems could strengthen adoption across consumer health and professional wellness channels.

The bottom line: - Liposomal supplements are moving from a niche category into a higher-growth segment of the nutrition market, with absorption claims, skincare demand and personalized wellness shaping the next phase of expansion.